VA
CVS icon

Valmark Advisers’s CVS Health CVS Stock Holding History

Valmark Advisers’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,592
Closed -$285K – 683
2025
Q4 		$285K Sell
3,592
-141
-4% -$11.1K ﹤0.01% 570
2025
Q3 		$281K Buy
3,733
+292
+8% +$20K ﹤0.01% 570
2025
Q2 		$237K Sell
3,441
-1,074
-24% -$70.4K ﹤0.01% 596
2025
Q1 		$306K Buy
+4,515
New +$270K ﹤0.01% 513
2024
Q4 		– Sell
-4,775
Closed -$300K – 596
2024
Q3 		$300K Sell
4,775
-310
-6% -$18.1K ﹤0.01% 501
2024
Q2 		$300K Sell
5,085
-386
-7% -$24.1K 0.01% 473
2024
Q1 		$436K Buy
5,471
+1,313
+32% +$100K 0.01% 401
2023
Q4 		$328K Sell
4,158
-656
-14% -$46.7K 0.01% 411
2023
Q3 		$336K Buy
4,814
+454
+10% +$32.2K 0.01% 384
2023
Q2 		$301K Sell
4,360
-55
-1% -$3.91K 0.01% 401
2023
Q1 		$328K Buy
4,415
+248
+6% +$20.8K 0.01% 379
2022
Q4 		$388K Buy
4,167
+289
+7% +$27.9K 0.01% 338
2022
Q3 		$370K Buy
3,878
+58
+2% +$5.74K 0.01% 319
2022
Q2 		$354K Buy
3,820
+1,071
+39% +$105K 0.01% 328
2022
Q1 		$278K Sell
2,749
-56
-2% -$5.88K ﹤0.01% 377
2021
Q4 		$289K Buy
2,805
+231
+9% +$21.3K 0.01% 353
2021
Q3 		$218K Sell
2,574
-286
-10% -$24K ﹤0.01% 370
2021
Q2 		$239K Buy
2,860
+184
+7% +$15.1K ﹤0.01% 357
2021
Q1 		$201K Buy
+2,676
New +$195K ﹤0.01% 367

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Valmark Advisers's CVS Position: Q1 2026 in Review

Valmark Advisers sold out of CVS Health (CVS) in Q1 2026, closing a stake of 3,592 shares — an estimated $285K sold.

Valmark Advisers first reported a position in CVS in Q1 2021 and held it in 19 quarters. The position peaked at $436K in Q1 2024. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Valmark Advisers reported no remaining CVS Health position as of Q1 2026 after selling out during the quarter.
  • Valmark Advisers sold 3,592 CVS Health shares in Q1 2026, an estimated $285K.
  • Valmark Advisers first reported a position in CVS Health in Q1 2021 and held it in 19 quarters.
  • Valmark Advisers's CVS Health position peaked at $436K in Q1 2024.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Valmark Advisers's 13F filing for Q1 2026, filed 1 May 2026.